CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -20.01% | -0.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -20.01% | -0.92% | |||
| Cost of Revenue | 20.82% | 7.50% | |||
| Gross Profit | -24.26% | -1.72% | |||
| SG&A Expenses | -19.62% | 16.58% | |||
| Depreciation & Amortization | 0.00% | 1.58% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.45% | 7.56% | |||
| Operating Income | -32.59% | -8.18% | |||
| Income Before Tax | -30.39% | -1.42% | |||
| Income Tax Expenses | -25.22% | -59.83% | |||
| Earnings from Continuing Operations | -32.68% | 175.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.68% | 175.33% | |||
| EBIT | -32.59% | -8.18% | |||
| EBITDA | -27.97% | -6.97% | |||
| EPS Basic | -32.19% | 193.71% | |||
| Normalized Basic EPS | -31.51% | -8.20% | |||
| EPS Diluted | -31.35% | 172.87% | |||
| Normalized Diluted EPS | -32.06% | -6.50% | |||
| Average Basic Shares Outstanding | -1.34% | 0.85% | |||
| Average Diluted Shares Outstanding | -0.54% | -0.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||